{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:31:19Z","timestamp":1778275879566,"version":"3.51.4"},"reference-count":170,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK078900"],"award-info":[{"award-number":["R01 DK078900"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK091310"],"award-info":[{"award-number":["R01 DK091310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.kint.2019.04.043","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T22:35:23Z","timestamp":1559255723000},"page":"555-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Summary of the International Conference on Onco-Nephrology: an emerging field in medicine"],"prefix":"10.1016","volume":"96","author":[{"given":"Anna","family":"Capasso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariella","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Capitanio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad R.","family":"Danesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar A.","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Malyszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell H.","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Trepiccione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Viggiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Zoccali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovambattista","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariga","family":"Akitaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Alahoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd R.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Altucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Barone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariela","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Biancone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph V.","family":"Bonventre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Camussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunato","family":"Ciardiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Capitanio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Caraglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Carten\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Citterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cosmai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad R.","family":"Danesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Daniele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonietta","family":"D\u2019Errico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ereditato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geppino","family":"Falco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Fouque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Gallieni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calvin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar A.","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Launay-Vacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evaristo","family":"Maiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Malysxko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Matarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piergiorgio","family":"Messa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Mirone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floriana","family":"Morgillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro Nanni","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Orditura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonello","family":"Pani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Anthony","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Pitts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camillo","family":"Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell H.","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian L.","family":"Siu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Trepiccione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Troiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Viggiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Weisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Wi\u0119cek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Xiaoqiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ortensio","family":"Zecchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Zoccali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2019.04.043_bib1","first-page":"1","article-title":"Deaths: final data for 2013","volume":"64","author":"Xu","year":"2016","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.kint.2019.04.043_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ndt\/gfv320","article-title":"Onco-nephrology: a decalogue","volume":"31","author":"Cosmai","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.04.043_bib3","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/sj.bjc.6605979","article-title":"Cancer and renal insufficiency results of the BIRMA study","volume":"103","author":"Janus","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccc.2009.09.002","article-title":"Acute kidney injury in critically ill patients with cancer","volume":"26","author":"Benoit","year":"2010","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.kint.2019.04.043_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055870","article-title":"Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival","volume":"8","author":"Canet","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2019.04.043_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2215\/CJN.03530412","article-title":"Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center","volume":"8","author":"Salahudeen","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejim.2011.05.005","article-title":"Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study","volume":"22","author":"Christiansen","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.kint.2019.04.043_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000329042","article-title":"Predicting hospital mortality in critically ill cancer patients according to acute kidney injury severity","volume":"80","author":"Lib\u00f3rio","year":"2011","journal-title":"Oncology"},{"key":"10.1016\/j.kint.2019.04.043_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/cc4907","article-title":"Clinical review: specific aspects of acute renal failure in cancer patients","volume":"10","author":"Darmon","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.kint.2019.04.043_bib10","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/cncr.22904","article-title":"Renal Insufficiency and Cancer Medications (IRMA) Study Group. Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study","volume":"110","author":"Launay-Vacher","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.semnephrol.2010.09.003","article-title":"Epidemiology of chronic kidney disease in cancer patients: lessons from the IRMA study group","volume":"30","author":"Launay-Vacher","year":"2010","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ajkd.2013.07.008","article-title":"Reduced estimated GFR and cancer mortality","volume":"63","author":"Iff","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.04.043_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000323740","article-title":"Chronic kidney disease in cancer: an independent predictor of cancer-specific mortality","volume":"33","author":"Na","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib14","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra1613984","article-title":"Acute kidney injury in patients with cancer","volume":"376","author":"Rosner","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.04.043_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.kint.2018.01.023","article-title":"Renal cell carcinoma for the nephrologist","volume":"94","author":"Perazella","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.04.043_bib16","doi-asserted-by":"crossref","first-page":"e3728","DOI":"10.1097\/MD.0000000000003728","article-title":"Renal function and all-cause mortality risk among cancer patients","volume":"95","author":"Yang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.kint.2019.04.043_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc.2016.140","article-title":"Interrogating open issues in cancer precision medicine with patient-derived xenografts","volume":"17","author":"Byrne","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2019.04.043_bib19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/PAT.0b013e3283437cac","article-title":"Ductal type signet ring cell carcinoma of breast with growth pattern of pure mucinous carcinoma","volume":"43","author":"Leung","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.kint.2019.04.043_bib20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","article-title":"Patient-derived tumour xenografts as models for oncology drug development","volume":"9","author":"Tentler","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.kint.2019.04.043_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","article-title":"Ex\u00a0vivo profiling of PD-1 blockade using organotypic tumor spheroids","volume":"8","author":"Jenkins","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.kint.2019.04.043_bib23","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2019.04.043_bib24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1073\/pnas.1401965111","article-title":"Genomic responses in mouse models greatly mimic human inflammatory diseases","volume":"112","author":"Takao","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2019.04.043_bib25","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2019.04.043_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","article-title":"Humanized mouse models of clinical disease","volume":"12","author":"Walsh","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.kint.2019.04.043_bib27","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2019.04.043_bib28","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1431","article-title":"Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1","volume":"12","author":"Melkus","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2019.04.043_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood-2005-11-4388","article-title":"Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus\/liver and CD34+ cell transplantation","volume":"108","author":"Lan","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.kint.2019.04.043_bib30","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1096\/fj.201700740R","article-title":"Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy","volume":"32","author":"Wang","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2019.04.043_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40425-019-0518-z","article-title":"Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts","volume":"7","author":"Capasso","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.lungcan.2011.11.016","article-title":"Estimation of renal function in lung cancer patients","volume":"76","author":"Trobec","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12032-013-0661-1","article-title":"A\u00a0comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma","volume":"30","author":"Quinton","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib35","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/annonc\/mdu129","article-title":"Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort","volume":"25","author":"Cathomas","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.lungcan.2012.10.009","article-title":"Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors","volume":"79","author":"Kaag","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib37","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/annonc\/mdr539","article-title":"Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients","volume":"23","author":"Ainsworth","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib38","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2017.72.7578","article-title":"New model for estimating glomerular filtration rate in patients with cancer","volume":"35","author":"Janowitz","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.04.043_bib40","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.ajkd.2007.11.018","article-title":"Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD","volume":"51","author":"Stevens","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.04.043_bib41","first-page":"7169897","article-title":"Incorporating cystatin C to predict methotrexate elimination in patients with CNS lymphoma and suspicious renal function","volume":"2018","author":"Barreto","year":"2018","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.kint.2019.04.043_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.canlet.2006.07.004","article-title":"Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma","volume":"248","author":"Mulaomerovi\u0107","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.kint.2019.04.043_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semnephrol.2016.01.008","article-title":"Quantifying glomerular filtration rates in acute kidney injury: a requirement for translational success","volume":"36","author":"Molitoris","year":"2016","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000453283","article-title":"Delay in renal hemodynamic response to a meat meal in severe obesity","volume":"136","author":"Anastasio","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2019.04.043_bib45","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ijc.24439","article-title":"Cancer incidence and risk factors after solid organ transplantation","volume":"125","author":"Vajdic","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib46","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejca.2012.09.013","article-title":"Risk of de novo cancers after transplantation","volume":"49","author":"Piselli","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib47","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/15665240113139990041","article-title":"De novo malignancies after organ transplantation: focus on viral infections","volume":"13","author":"Piselli","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.kint.2019.04.043_bib48","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.1114233","article-title":"Azathioprine and UVA light generate mutagenic oxidative DNA damage","volume":"309","author":"O\u2019Donovan","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.kint.2019.04.043_bib49","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/ki.2013.458","article-title":"Malignancy-related mortality following kidney transplantation is common","volume":"85","author":"Farrugia","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.04.043_bib50","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/bjs.9460","article-title":"Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry","volume":"101","author":"Desai","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.kint.2019.04.043_bib51","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/ndt\/gfu216","article-title":"European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care","volume":"30","author":"Abramowicz","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.04.043_bib52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/ckj\/sfv054","article-title":"Management and prevention of post-transplant malignancies in kidney transplant recipients","volume":"8","author":"Stallone","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2019.04.043_bib53","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.amjhyper.2004.08.010","article-title":"Microalbuminuria and cardiovascular risk","volume":"17","author":"Karalliedde","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.kint.2019.04.043_bib54","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2019.04.043_bib55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.amjcard.2007.08.041","article-title":"Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004)","volume":"101","author":"Kshirsagar","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.kint.2019.04.043_bib56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.jhh.1001408","article-title":"Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension","volume":"16","author":"Leoncini","year":"2002","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.kint.2019.04.043_bib57","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1158\/1055-9965.EPI-10-0617","article-title":"Association of albuminuria and cancer mortality","volume":"19","author":"Lin","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.kint.2019.04.043_bib58","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1681\/ASN.2007060712","article-title":"Association of albuminuria and cancer incidence","volume":"19","author":"Jorgensen","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib59","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ki.2013.553","article-title":"Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar","volume":"86","author":"Wen","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.04.043_bib60","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib61","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1681\/ASN.2008090998","article-title":"Association of CKD and cancer risk in older people","volume":"20","author":"Wong","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib62","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2215\/CJN.09011010","article-title":"Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort","volume":"6","author":"Weng","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib63","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/nep.13269","article-title":"Nephrologists\u2019 perspectives on cancer screening in patients with chronic kidney disease: an interview study","volume":"24","author":"James","year":"2019","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2019.04.043_bib64","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/s12885-017-3705-7","article-title":"Renal failure during chemotherapy: renal biopsy for assessing subacute nephrotoxicity of pemetrexed","volume":"17","author":"Assayag","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib65","first-page":"S111","article-title":"The results of radical nephrectomy for renal cell carcinoma","volume":"197","author":"Robson","year":"2017","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.kint.2019.04.043_bib66","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0140-6736(15)00046-X","article-title":"Renal cancer","volume":"387","author":"Capitanio","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2019.04.043_bib67","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.eururo.2013.06.044","article-title":"Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904","volume":"65","author":"Scosyrev","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.kint.2019.04.043_bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2019.04.043_bib69","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(07)61904-7","article-title":"Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a\u00a0randomised, double-blind phase III trial","volume":"370","author":"Escudier","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2019.04.043_bib70","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2019.04.043_bib71","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1200\/JCO.2008.16.9847","article-title":"Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206","volume":"26","author":"Rini","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib72","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1200\/JCO.2009.23.9764","article-title":"Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial","volume":"28","author":"Sternberg","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib73","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1303989","article-title":"Pazopanib versus sunitinib in metastatic renal-cell carcinoma","volume":"369","author":"Motzer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2019.04.043_bib74","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1200\/JCO.2012.47.4940","article-title":"Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial","volume":"31","author":"Motzer","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejca.2018.02.012","article-title":"Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): progression-free survival by independent review and overall survival update","volume":"94","author":"Choueiri","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib76","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.eururo.2017.03.037","article-title":"Treatment beyond progression in patients with advanced renal cell carcinoma treated with Nivolumab in CheckMate 025","volume":"72","author":"Escudier","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.kint.2019.04.043_bib77","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41591-018-0053-3","article-title":"Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma","volume":"24","author":"McDermott","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2019.04.043_bib78","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2018.10.010","article-title":"Systemic treatment of metastatic clear cell renal cell carcinoma in 2018: current paradigms, use of immunotherapy, and future directions","volume":"75","author":"Lalani","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.kint.2019.04.043_bib79","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.eururo.2018.07.029","article-title":"Below safety limits, every unit of glomerular filtration rate counts: assessing the relationship between renal function and cancer-specific mortality in renal cell carcinoma","volume":"74","author":"Antonelli","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.kint.2019.04.043_bib80","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.eururo.2018.08.040","article-title":"Do we truly care about the functional outcomes for renal cancer patients? Multidisciplinarity is still far away","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.kint.2019.04.043_bib81","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/bjc.2016.329","article-title":"MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma","volume":"115","author":"Trevisani","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib82","first-page":"155","article-title":"Genomic and proteomic approaches to renal cell carcinoma","volume":"24","author":"Zacchia","year":"2011","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib83","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2215\/CJN.03770412","article-title":"Onco-nephrology: glomerular diseases with cancer","volume":"7","author":"Cambier","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib84","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1080\/10428194.2017.1379075","article-title":"French Network of systemic and immune disorders associated with hemopathies and cancer (MINHEMON). Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study","volume":"59","author":"Jachiet","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.kint.2019.04.043_bib85","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1523-1755.2003.00771.x","article-title":"Glomerulonephritis and malignancy: a population-based analysis","volume":"63","author":"Birkeland","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.04.043_bib86","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/sj.ki.5001790","article-title":"Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association","volume":"70","author":"Lefaucheur","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.04.043_bib87","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000183483","article-title":"Kidney and cancer: results of immunofluorescence microscopy","volume":"40","author":"Beaufils","year":"1985","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2019.04.043_bib88","first-page":"43","article-title":"Electron microscopy and immunofluorescence of glomerular immune complex deposits in cancer patients","volume":"36","author":"Pascal","year":"1976","journal-title":"Cancer Res"},{"key":"10.1016\/j.kint.2019.04.043_bib89","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/ndt\/gfr534","article-title":"Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy","volume":"27","author":"Qu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.04.043_bib90","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","article-title":"Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats","volume":"18","author":"Lai","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib91","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000083474","article-title":"Rectal cancer with paraneoplastic nephropathy: association of vascular endothelial growth factor","volume":"21","author":"Taniguchi","year":"2004","journal-title":"Dig Surg"},{"key":"10.1016\/j.kint.2019.04.043_bib92","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D","article-title":"Wegener\u2019s granulomatosis associated with renal cell carcinoma","volume":"42","author":"Tatsis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2019.04.043_bib93","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1681\/ASN.V85848","article-title":"Nephrotic syndrome, renal failure, and renal malignancy: an unusual tumor-associated glomerulonephritis","volume":"8","author":"Ahmed","year":"1997","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib94","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000409763","article-title":"IgA mesangial nephropathy in neoplastic diseases","volume":"40","author":"Mustonen","year":"1984","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib95","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2215\/CJN.02780312","article-title":"Onco-nephrology: renal toxicities of chemotherapeutic agents","volume":"7","author":"Perazella","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib96","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1200\/JCO.1989.7.6.781","article-title":"Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry","volume":"7","author":"Lesesne","year":"1989","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib97","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.kint.2019.04.043_bib98","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/ndt\/gfl507","article-title":"Gemcitabine-induced thrombotic microangiopathy: a systematic review","volume":"21","author":"Izzedine","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.04.043_bib99","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.04.043_bib100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jash.2018.03.008","article-title":"Vascular toxicities with VEGF inhibitor therapies\u2014focus on hypertension and arterial thrombotic events","volume":"12","author":"Touyz","year":"2018","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.kint.2019.04.043_bib101","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2019.04.043_bib102","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.kint.2019.04.043_bib103","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajh\/3.3.204","article-title":"The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity","volume":"3","author":"Capasso","year":"1990","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.kint.2019.04.043_bib104","first-page":"184","article-title":"Parathyroidectomy has a beneficial effect on experimental cisplatin nephrotoxicity","volume":"33","author":"Capasso","year":"1990","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-4684-8953-8_33","article-title":"The effect of parathyroid hormone on cisplatin nephrotoxicity","volume":"252","author":"Capasso","year":"1989","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.kint.2019.04.043_bib106","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.1073\/pnas.1203129109","article-title":"Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity","volume":"109","author":"Sengupta","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2019.04.043_bib107","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI37829","article-title":"Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models","volume":"119","author":"Brooks","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2019.04.043_bib108","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI77632","article-title":"Sirtuin 3\u2013dependent mitochondrial dynamic improvements protect against acute kidney injury","volume":"125","author":"Marina","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2019.04.043_bib109","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1158\/1078-0432.CCR-06-1037","article-title":"Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis","volume":"12","author":"Yang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.kint.2019.04.043_bib110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ki.2012.441","article-title":"Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology","volume":"83","author":"Zhan","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.04.043_bib111","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.semnephrol.2016.01.005","article-title":"Mitochondria in acute kidney injury","volume":"36","author":"Ralto","year":"2016","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib112","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000444370","article-title":"Mitochondrial sirtuin 3 and renal diseases","volume":"134","author":"Perico","year":"2016","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2019.04.043_bib113","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1681\/ASN.2017111218","article-title":"Sirtuins in renal health and disease","volume":"29","author":"Morigi","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib114","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI77632","article-title":"Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury","volume":"125","author":"Morigi","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2019.04.043_bib115","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41467-017-00937-2","article-title":"Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function","volume":"8","author":"Perico","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2019.04.043_bib116","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1038\/ncomms7656","article-title":"Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3","volume":"6","author":"Pillai","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2019.04.043_bib117","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10753-014-9845-x","article-title":"Effects of honokiol on sepsis-induced acute kidney injury in an experimental model of sepsis in rats","volume":"37","author":"Li","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.kint.2019.04.043_bib118","doi-asserted-by":"crossref","first-page":"39592","DOI":"10.18632\/oncotarget.17165","article-title":"SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.kint.2019.04.043_bib119","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrneph.2017.5","article-title":"Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases","volume":"13","author":"Hershberger","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib120","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrm.2016.93","article-title":"Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds","volume":"17","author":"Bonkowski","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.kint.2019.04.043_bib121","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41591-018-0138-z","article-title":"De novo NAD+ biosynthetic impairment in acute kidney injury in humans","volume":"24","author":"Poyan Mehr","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2019.04.043_bib122","first-page":"4A","article-title":"Immune-related adverse events (irAEs) following CTLA-4 and PD-1\/PD-L1 blockade in advanced melanoma: a comprehensive rapid autopsy study","volume":"29","author":"Hammers","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.kint.2019.04.043_bib123","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PAP.0000000000000122","article-title":"Antineoplastic treatment and renal injury: an update on renal pathology due to cytotoxic and targeted therapies","volume":"23","author":"Troxell","year":"2016","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.kint.2019.04.043_bib124","first-page":"475","article-title":"Acute kidney injury and electrolyte disorders in the critically ill patient with cancer","volume":"23","author":"Rosner","year":"2017","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.kint.2019.04.043_bib125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.ajkd.2011.08.029","article-title":"Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes","volume":"59","author":"Doshi","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.04.043_bib126","first-page":"192","article-title":"A\u00a0prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis","volume":"8","author":"Berghmans","year":"2000","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib127","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2265.2006.02583.x","article-title":"Characteristics and mortality of severe hyponatraemia\u2014a hospital-based study","volume":"65","author":"Gill","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.kint.2019.04.043_bib128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejca.2018.08.019","article-title":"A\u00a0study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials","volume":"104","author":"Ingles Garces","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/j.ackd.2013.05.005","article-title":"Electrolyte disorders associated with cancer","volume":"21","author":"Rosner","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2019.04.043_bib130","first-page":"1","article-title":"Hyponatremia associated with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact","volume":"4","author":"Penttil\u00e4","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib131","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12885-016-2610-9","article-title":"The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients","volume":"16","author":"Castillo","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib132","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11060-018-2774-z","article-title":"The predictive potential of hyponatremia for glioblastoma patient survival","volume":"138","author":"Mrowczynski","year":"2018","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.kint.2019.04.043_bib133","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2016.02.064","article-title":"Electrolyte disorders associated with the use of anticancer drugs","volume":"777","author":"Liamis","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.kint.2019.04.043_bib134","article-title":"Risk of hyponatremia in cancer patients treated with targeted therapies: a systematic review and meta-analysis of clinical trials","volume":"11","author":"Beradi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2019.04.043_bib135","first-page":"6595","article-title":"An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A)","volume":"9","author":"Enzoe","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.kint.2019.04.043_bib136","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12020-018-1547-y","article-title":"Practical issues for the management of hyponatremia in oncology","volume":"61","author":"Berardi","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.kint.2019.04.043_bib137","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/0284186X.2017.1378430","article-title":"Diagnosis of hyponatremia and increased risk of a subsequent cancer diagnosis: results from a nationwide population-based cohort study","volume":"57","author":"Holland-Bill","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib138","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejim.2016.07.028","article-title":"Hyponatremia, all-cause mortality, and risk of cancer diagnosis in the primary care setting: a large population study","volume":"36","author":"Selmer","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.kint.2019.04.043_bib139","first-page":"2275","article-title":"Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study","volume":"25","author":"Burst","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/cam4.805","article-title":"Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials","volume":"6","author":"Gralla","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.kint.2019.04.043_bib141","doi-asserted-by":"crossref","first-page":"23871","DOI":"10.18632\/oncotarget.13372","article-title":"Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy","volume":"8","author":"Beradi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.kint.2019.04.043_bib142","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.kint.2016.12.005","article-title":"Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus","volume":"91","author":"Khositseth","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.04.043_bib143","first-page":"1871","article-title":"The frequency, cost and clinical outcomes of hypernatremia in patients hospitalized to a comprehensive cancer center","volume":"21","author":"Salahudeen","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib144","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cam4.749","article-title":"Prevalence of hypercalcemia among cancer patients in the United States","volume":"5","author":"Gastanaga","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.kint.2019.04.043_bib145","first-page":"728","article-title":"Malignancy-related hypercalcemia in advanced solid tumors: survival outcomes","volume":"3","author":"Ramos","year":"2017","journal-title":"J\u00a0Glob Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib146","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/ejh.12923","article-title":"Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma in the era of novel antimyeloma therapies","volume":"99","author":"Zagouri","year":"2017","journal-title":"Eur J Hematol"},{"key":"10.1016\/j.kint.2019.04.043_bib147","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2215\/CJN.02470312","article-title":"Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia","volume":"7","author":"Rosner","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib148","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2217\/fon.12.76","article-title":"The multifaceted actions of PTHrP in skeletal metastasis","volume":"8","author":"Soki","year":"2012","journal-title":"Future Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib149","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1210\/jc.2013-2016","article-title":"Calcitriol-mediated hypercalcemia: causes and course in 101 patients","volume":"98","author":"Donovan","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2019.04.043_bib150","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1210\/jc.2012-2142","article-title":"Parathyroid hormone-related protein: an update","volume":"97","author":"Wysolmerski","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2019.04.043_bib151","first-page":"285","article-title":"Myeloma bone disease: pathogenesis and treatment","volume":"15","author":"O\u2019Donnell","year":"2017","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib152","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.2217\/fon.15.232","article-title":"Denosumab: a new agent in the management of hypercalcemia of malignancy","volume":"11","author":"Thosani","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib153","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00280-017-3392-8","article-title":"Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management","volume":"80","author":"Oronsky","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.kint.2019.04.043_bib154","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archinte.1981.00340060094021","article-title":"Hypokalemia in nonblastic chronic myelogenous leukemia","volume":"141","author":"Evans","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.kint.2019.04.043_bib155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2002.tb04419.x","article-title":"Association of hypertension and hypokalemia with Cushing\u2019s syndrome caused by ectopic ACTH secretion: a series of 58 cases","volume":"970","author":"Torpy","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.kint.2019.04.043_bib156","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/1759-7714.12403","article-title":"Ectopic Cushing syndrome in small cell lung cancer: a case report and literature review","volume":"8","author":"Zhang","year":"2017","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.kint.2019.04.043_bib157","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000351804","article-title":"Spurious electrolyte disorders: a diagnostic challenge for clinicians","volume":"38","author":"Liamis","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2019.04.043_bib158","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13054-016-1382-6","article-title":"Acute kidney injury in critically ill cancer patients: an update","volume":"20","author":"Lameire","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.kint.2019.04.043_bib159","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/17474086.2016.1127156","article-title":"Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency","volume":"9","author":"Criscuolo","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.kint.2019.04.043_bib160","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0889-8588(05)70126-X","article-title":"Acquired Fanconi\u2019s syndrome associated with monoclonal gammopathies","volume":"13","author":"Lacy","year":"1999","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.kint.2019.04.043_bib161","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","article-title":"Tumor-induced osteomalacia","volume":"13","author":"Minisola","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.kint.2019.04.043_bib162","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0009-9120(95)00013-Y","volume":"28","author":"Larner","year":"1985","journal-title":"Pseudohyperphosphatemia. Clin Biochem"},{"key":"10.1016\/j.kint.2019.04.043_bib163","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11739-018-1898-7","article-title":"Extreme hypomagnesemia: characteristics of 119 consecutive inpatients","volume":"13","author":"Cheminet","year":"2018","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.kint.2019.04.043_bib164","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/ndt\/gfw467","article-title":"Adverse kidney effects of epidermal growth\u00a0factor receptor inhibitors","volume":"32","author":"Izzedine","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.04.043_bib165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1517\/13543784.17.1.85","article-title":"Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain","volume":"17","author":"Davis","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.kint.2019.04.043_bib166","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm0602-547","article-title":"Targeting the endocannabinoid system in cancer therapy: a call for further research","volume":"8","author":"Bifulco","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2019.04.043_bib167","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/978-3-319-20825-1_16","article-title":"Endocannabinoids and cancer","volume":"231","author":"Velasco","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.kint.2019.04.043_bib168","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.3747\/co.23.3080","article-title":"Anticancer mechanisms of cannabinoids","volume":"23","author":"Velasco","year":"2016","journal-title":"Curr Oncol"},{"key":"10.1016\/j.kint.2019.04.043_bib169","first-page":"51","article-title":"FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels","volume":"11","author":"Petrosino","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.kint.2019.04.043_bib170","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/bph.14426","article-title":"Anti-tumour actions of cannabinoids","volume":"176","author":"Hinz","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.kint.2019.04.043_bib171","doi-asserted-by":"crossref","unstructured":"Viggiano D, Capasso A, Capasso G. A quest for protecting kidneys from cisplatin toxicity [e-pub ahead of print]. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfz029. Accessed February 27, 2019.","DOI":"10.1093\/ndt\/gfz029"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819305897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819305897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:53:40Z","timestamp":1758761620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253819305897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":170,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0085253819305897"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2019.04.043","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Summary of the International Conference on Onco-Nephrology: an emerging field in medicine","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2019.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}